期刊文献+

FAT10基因表达与结直肠癌患者临床病理因素及预后的关系 被引量:2

Analysis the Relatvie of FAT10 Expression with Clinicopathological Features and Prognosis of Colorectal Cancer
下载PDF
导出
摘要 目的:探讨结直肠癌(CCT)组织中FAT10(Diubiquitin,双泛素)的基因表达与其病理因素及预后的关系。方法:收集我院2000~2003年73例有5年以上完整随访资料的结直肠癌术后患者,采用RT-PCR方法检测FAT10 mRNA在CCT、癌旁组织(TCT)和正常结直肠组织(NCT)中的表达情况,并分析临床病理因素对FAT10阳性表达率和相对表达量的影响,以及FAT10表达与预后的关系。结果:FAT10 mRNA在CCT阳性表达率为52.24%(35/67),且在CCT的相对表达量(0.735±0.034)明显高于TCT(0.561±0.044)和NCT(0.397±0.028)(P<0.05);FAT10 mRNA的阳性表达率及相对表达量受临床进展、淋巴结转移和TNM分级的影响较明显(P<0.05),而患者年龄、肿瘤大小、肿瘤分化程度等对其无明显影响(P>0.05);Log-Rank检验显示CCT患者中,FAT10表达阳性者生存率明显低于FAT10表达阴性者(P<0.01)。结论:FAT10在CCT的表达状况与CCT转移及预后关系密切,可以作为反映生物学行为和判断预后的有效指标。 Objective:To investigate the relationship between expression of FAT10 in colorectal cancer and its clinicopathologic significance.Method:Collected 73 cases in 2000~2003 in our hospital over 5 years follow-up data complete the colorectal cancer patients using RT-PCR to detect FAT10 mRNA expression in colorectal cancer tissues and tumor adjacent tissue,the normal colon tissue as control,and relation of FAT10 expression with clinicopathological features and clinical outcomes of colorectal cancer patients were analyzed.Results:The intensive positive rate of FAT10 mRAN expression in colorectal cancer was 52.24%(35/67).Expression of FAT10 was significantly correlated with lymph node metastasis and clinical stage and TNM staging(P<0.05),but not with age,tumor size and tumor differentiation,etc.(P>0.05).In the intensive positive rate of FAT10 expression in colorectal cancer,the survival rate was significantly lower than negative ones(P<0.01).Conclusion:Overexpression of FAT10 in patients with colorectal cancer enhances the possibility of invasion and metastasis,implying apoor prognosis.FAT10 may serve as fairly agood prognostic factor to indicate biologic behavior and prognosis in colorectal cancer.
出处 《微循环学杂志》 2011年第2期19-22,I0001,共5页 Chinese Journal of Microcirculation
关键词 FAT10基因 结直肠癌 预后 FAT10 gene Colorectal cancer Prognosis
  • 相关文献

参考文献11

  • 1Smith RA,Cokkinides V,Brawley OW.Cancer screening in the united states,2008:a review of current american cancer society guidelines and cancer screening issues.CA Cancer J Clin,2008,58(3):161-179. 被引量:1
  • 2宋武,何裕隆,蔡世荣,张常华,陈创奇,张信华,彭建军,詹文华.结直肠腺癌病理分型的临床意义及预后分析[J].中华消化杂志,2009,29(4):249-253. 被引量:6
  • 3Ren J,Kan A,Leong SH,et al.FAT10 plays a role in the regulation of chromosomal stability.J Biol Chem,2006,281(16):11 413-11 421. 被引量:1
  • 4Schmidtke G,Kalveram B,Weber E,et al.The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.J Biol Chem,2006,281(29):20 045-20 054. 被引量:1
  • 5Snyder A,Alsauskas Z,Gong P,et al.FAT10:a novel mediator of Vpr-induced apoptosis in human immunodeficiency virus-associated nephropathy.J Virol,2009,83(22):11 983-11 988. 被引量:1
  • 6Gong P,Canaan A,Wang B,et al.The ubiquitin-like protein FAT10 mediates NF-kappaB activation.J Am Soc Nephrol,2010,21(2):316-326. 被引量:1
  • 7Lee CG,Ren J,Cheong IS,et al.Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers.Oncogene,2003,22(17):2 592-2 603. 被引量:1
  • 8Zhang,SH,Xu,AM,Chen,XF,et al.Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.Hum Pathol,2008,39(12):1 827-1 834. 被引量:1
  • 9Ross MJ,Wosnitzer MS,Ross MD,et al.Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease.J Am Soc Nephrol,2006,17(4):996-1 004. 被引量:1
  • 10Oliva J,Bardag-Gorce F,French BA,et al.Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis.Exp Mol Pathol,2008,84(2):102-112. 被引量:1

二级参考文献15

  • 1Kang H, outcomes carcinoma 2005, 48 : O' Connell JB, Maggard MA, et al. A 10-year evaluation of mucinous and signet ring cell of the colon and rectum. Dis Colon Rectum, 1161-1168. 被引量:1
  • 2Kanemitsu Y, Kato T, Hirai T, et ai. Survival after curative resection for mutinous adenocarcinoma of the colorectum. Dis Colon Rectum, 2003,46 : 160-167. 被引量:1
  • 3Longo R, Morabito A, Carillio G, et al. Muhiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical course. Int J Gastrointest Cancer, 2006, 37,49-54. 被引量:1
  • 4Maksimovie S. Survival rates of patients with mucinous adenocareinoma of the colorectum. Med Arh, 2007, 61 : 26- 29. 被引量:1
  • 5Nozoe T, Anai H, Nasu S, et al. Ctinicopathological characteristics of mutinous carcinoma of the colon and rectum. J Surg Oneol, 2000,75 : 103-107. 被引量:1
  • 6Human colorectal cancer. The Mouse Models of Human Cancers Consortium (MMHCC) Cancer Models Data- base. Available at: http:// emice, nci. nih. gov/emice/mouse_ models/organ_ models/gastro models/human_ colorectal_ cancer. :2008. 被引量:1
  • 7Younes M, Katikaneni PR, Lechago J. The value of the preoperative mucosal biopsy in the diagnosis of coloreetal mueinous adenocarcinoma. Cancer, 1993,72:3588-3592. 被引量:1
  • 8Du W, Mah JT, Lee J, et al. Incidence and survival of mucinous adenocarcinoma of the colorectum: a populationbased study from an Asian country. Dis Colon Rectum, 2004, 47:78-85. 被引量:1
  • 9Kakar S, Aksoy S, Burgart LJ, et al. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathotogic features and survival. Mod Pathol, 2004,17 : 696-700. 被引量:1
  • 10King-Yin Lain A, Ong K, Ho YH. Coloreetal mueinous adenoeareinoma : the elinieopathologie features and significance of p16 and p53 expression. Dis Colon Rectum, 2006,49 : 1275-1283. 被引量:1

共引文献5

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部